These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25987234)

  • 41. Risk stratification of CAD with SPECT-MPI in women with known estrogen status.
    Sood N; Kazi FA; Lundbye JB; Katten D; Heller GV
    J Nucl Cardiol; 2012 Apr; 19(2):330-7. PubMed ID: 22259010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.
    Cury RC; Kitt TM; Feaheny K; Akin J; George RT
    J Cardiovasc Comput Tomogr; 2014; 8(1):2-12. PubMed ID: 24314823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging.
    Fughhi I; Campagnoli T; Ali A; Doukky R
    J Nucl Cardiol; 2017 Oct; 24(5):1571-1578. PubMed ID: 27233251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.
    Gomez J; Golzar Y; Fughhi I; Olusanya A; Doukky R
    J Nucl Cardiol; 2018 Aug; 25(4):1313-1323. PubMed ID: 28181156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease.
    Gimelli A; Rossi G; Landi P; Marzullo P; Iervasi G; L'abbate A; Rovai D
    J Nucl Med; 2009 Apr; 50(4):546-53. PubMed ID: 19289433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.
    Bhatti S; Hakeem A; Dhanalakota S; Palani G; Husain Z; Jacobsen G; Ananthasubramaniam K
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):933-40. PubMed ID: 24699324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.
    Parker MW; Morales DC; Slim HB; Ahlberg AW; Katten DM; Cyr G; Mathur S; Ardestani A; Barmpouletos D; Iyah GS; Borer SM; Heller GV
    J Nucl Cardiol; 2013 Apr; 20(2):185-96. PubMed ID: 23188626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of high-risk coronary artery disease in subjects with normal SPECT myocardial perfusion imaging.
    Nakanishi R; Gransar H; Slomka P; Arsanjani R; Shalev A; Otaki Y; Friedman JD; Hayes SW; Thomson LE; Fish M; Germano G; Abidov A; Shaw L; Rozanski A; Berman DS
    J Nucl Cardiol; 2016 Jun; 23(3):530-41. PubMed ID: 25971987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.
    Janvier L; Pinaquy J; Douard H; Karcher G; Bordenave L
    J Nucl Cardiol; 2017 Feb; 24(1):34-40. PubMed ID: 26542990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of automated vs visual analysis for adenosine stress myocardial perfusion SPECT in patients without prior coronary artery disease: a case-control study.
    Xu Y; Nakazato R; Hayes S; Hachamovitch R; Cheng VY; Gransar H; Miranda-Peats R; Hyun M; Shaw LJ; Friedman J; Germano G; Berman DS; Slomka PJ
    J Nucl Cardiol; 2011 Dec; 18(6):1003-9; quiz 1010-4. PubMed ID: 21932154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
    Katz JS; Ruisi M; Giedd KN; Rachko M
    J Nucl Cardiol; 2012 Aug; 19(4):727-34. PubMed ID: 22527801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
    Amer KA; Hurren JR; Edwin SB; Cohen G
    Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Ballany W; Mansour K; Morales Demori R; Al-Amoodi M; Doukky R
    J Nucl Cardiol; 2014 Jun; 21(3):496-502. PubMed ID: 24519563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the prognostic value of myocardial perfusion imaging using a CZT-SPECT camera with a conventional anger camera.
    Lima R; Peclat T; Soares T; Ferreira C; Souza AC; Camargo G
    J Nucl Cardiol; 2017 Feb; 24(1):245-251. PubMed ID: 27510176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance and safety profile of regadenoson myocardial perfusion imaging: first experience in Greece.
    Koutsikos J; Angelidis G; Zafeirakis A; Mamarelis I; Vogiatzis M; Ilia E; Lazaridis K; Demakopoulos N
    Hell J Nucl Med; 2017; 20(3):232-236. PubMed ID: 29177261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of Stress Dynamic Myocardial Perfusion CT in a Multicenter Population With Known or Suspected Coronary Artery Disease.
    Meinel FG; Pugliese F; Schoepf UJ; Ebersberger U; Wichmann JL; Lo GG; Choe YH; Wang Y; Segreto S; Bamberg F; De Cecco CN
    AJR Am J Roentgenol; 2017 Apr; 208(4):761-769. PubMed ID: 28177653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of absent left ventricular ejection fraction reserve with regadenoson SPECT MPI.
    Smith P; Farag A; Bhambhvani P; Iskandrian A; Hage FG
    J Nucl Cardiol; 2022 Jun; 29(3):978-986. PubMed ID: 33089878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic value of mechanical left ventricular dyssynchrony defined by phase analysis from gated single-photon emission computed tomography myocardial perfusion imaging among patients with coronary heart disease.
    Hess PL; Shaw LK; Fudim M; Iskandrian AE; Borges-Neto S
    J Nucl Cardiol; 2017 Apr; 24(2):482-490. PubMed ID: 26809439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.